Dr. Moise Khayrallah is a member of the Supervisory Board of the Lebanon Dialogue Initiative. Dr. Khayrallah has been involved in drug development for 25 years in executive as well as research and development positions. He acquired his experience in diverse pharmaceutical environments including large pharmaceutical, contract research, and biotechnology companies. In 2010, Dr. Khayrallah was co-founder, President and CEO of Neuronex Inc, a company focused on developing treatments for patients with certain seizure disorders.  Neuronex announced the signing of an agreement to be acquired by Acorda Therapeutics in February 2012.  In 2006, he co-founded and served as President and CEO of Addrenex Pharmaceuticals, Inc., a specialty pharmaceuticals company that developed and received FDA approvals for compounds targeting the adrenergic system. Addrenex was acquired in late 2009 by Shionogi & Co. of Japan with multiple investment returns for shareholders. In 2002, Dr. Khayrallah founded a consulting company, Alius Pharma, LLC, to partner with small biotechnology companies in cancer drug development. From 1999 to 2002, he was VP of Clinical Affairs at Cytran, Inc., a Seattle area biotechnology company, where he led the product development team for the company’s lead compound in cancer and participated in financing and joint venture activities. Prior to that, Dr. Khayrallah served as Director, Clinical Research and Regulatory Affairs at Lineberry Research Associates (later Constella Group and SRI International) in RTP, NC. While at Lineberry, he led project teams in implementing clinical projects and providing strategic consulting in several therapeutic areas. Dr. Khayrallah also served in various positions at Burroughs Wellcome and later Glaxo Wellcome from 1987 to 1996, where he led clinical programs and trials resulting in FDA approvals in CNS indications. He holds a PhD degree in psychology from the University of North Carolina at Chapel Hill.


Follow us on social media

Sign up for newsletter

Notre Dame University - NDU

P.O. Box: 72 Zouk Mikael


Tel: +961 9 208 992

Mobile: +961 71 878 646

Email: info@lebanondialogue.org

Website: www.lebanondialogue.org

© www.ldi-lb.org, Inc. All rights reserved. Unless otherwise indicated, all materials on these pages are copyrighted.